Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema

PHASE2TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Diabetic Macular Edema
Interventions
DRUG

Aliskiren

300 mg once daily

DRUG

Placebo

Matching placebo once daily

Trial Locations (12)

Unknown

Retinal Consultants of Arizona, Phoenix

Retina-Vitreous Associates, Los Angeles

National Ophthalmic Research Institute, Fort Myers

Georgia Retina, Atlanta

Elman Retina Group, Baltimore

Vitreo-Retinal Associates, Grand Rapids

Retina-Associates of Cleveland, Inc, Beachwood

Novartis Investigative Site, Aarhus

Novartis Investigative Site, Copenhagen

MA

Joslin Clinic, Boston

NC

Charlotte Eye, Ear, Nose and Throat Associate, Charlotte

TX

Retinal Consultants of Houston, Houston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY